American Marconi Wireless News

Diginex Revenues Surge as "Proof" Becomes Essential

BOCA RATON, FL / ACCESS Newswire / December 9, 2025 / There's a shift happening across global business that few companies are prepared for. Regulators, investors, and supply-chain partners no longer want sustainability claims. They want proof. They want data that can be traced, audited, verified, and defended. The era of polished ESG reports is over. What matters now is evidence that survives scrutiny. That shift is creating an entirely new category inside corporate governance, the verification layer. And that's exactly where Diginex (NASDAQ:DGNX) is planting its flag.

CXAI Announces Results from Landmark Enterprise Deployment as Global Workplace Disruption Creates an up to Trillion Dollar Agentic AI Opportunity For Employee Engagement

Enterprise adoption accelerates as CXAI strengthens its position at the center of the workplace experience and enterprise Agentic AI markets

Majority of Australian Parents (65%) and U.S. Parents 58% Support Social Media Ban for Under 16s, but Kids Say It Risks Cutting Them Off from Key Connections

New survey of 4,000 parents and children in the U.S. and Australia reveals sharp generational divides in support, fears, mental health expectations, and belief in government enforcement.

e& Selects Amdocs to Power Its Generative AI Experiences

Leveraging Amdocs' amAIz - generative AI Platform and its agents, powered by NVIDIA AI Enterprise, e& UAE is integrating generative AI into its business processes, opening possibilities for new revenue opportunities, business efficiencies, and improved customer experiences

Athena Bitcoin Celebrates Bitcoin Origins Month by Recognizing the Moment the World's Most Popular Cryptocurrency Went Mobile

Learn about the turning point that put Bitcoin in the palm of the world's hands

HUB Cyber Security Builds the Hardware Root of Digital Truth

TEL AVIV, IL / ACCESS Newswire / December 9, 2025 / Some companies chase attention. HUB Cyber Security (NASDAQ:HUBC) builds assets that command it on its own. The rollout of HUB Compliance™ shows exactly why. This isn't another dashboard, plug-in, or point tool for overloaded IT teams. HUB Compliance™ is a trust engine designed for sectors where data rules are strict, disclosure deadlines matter, and institutions cannot afford to get compliance wrong at scale.

SideChannel Announces Anna Seacat Appointed to Board of Directors

WORCESTER, MA / ACCESS Newswire / December 9, 2025 / SideChannel, Inc. (OTCQB:SDCH) ("SideChannel"), a leading provider of cybersecurity services and technology from emerging to enterprise companies, today announced the appointment Anna Seacat to its Board of Directors underscoring SideChannel's dedication to leadership excellence and innovation in addressing cybersecurity challenges.

Autonomous Finance Needs a Control Layer; HUB Cyber Security Is Building It

TEL AVIV, IL / ACCESS Newswire / December 9, 2025 / A fundamental shift is taking place across global finance. Institutions are not simply modernizing their workflows or migrating legacy systems into the cloud. They are preparing for a future defined by autonomous engines that operate at speeds and levels of precision no human team can match. Trading models driven by machine reasoning, real-time settlement networks, automated underwriting, onboarding, and identity flows built on authentication are becoming the new operating standard. Software is no longer supporting decisions. It is making them.

BCII Enterprises Inc. Launches Coupon Token System: 2% Mortgage Discounts for 46m Renters, Down-Payment Grants for Exercising Users, 10% Tax Relief for 175m Americans, and Corporate Token Buy-Ins Targeting Deficit Elimination in 18 Months

Patent-Pending Coupon Token Architecture Demonstrates Unprecedented Scalability Across Housing, Tax Policy, and Corporate Finance Creating Multi-Billion Dollar Revenue Opportunity for BCII

Trump says to sign order blocking AI regulation by states

President Donald Trump said Monday he will attempt to strip states of the right to regulate the surging AI industry, arguing centralized rulemaking is vital to maintain US dominance.

AI tools help choose best embryos for IVF

Artificial intelligence tools can now help choose the most promising embryos for in vitro fertilisation (IVF), although experts have warned of some ethical concerns.

intive Announces Strategic Enterprise Partnership with Cursor to Advance AI-Native Transformation

REGENSBURG, DE / ACCESS Newswire / December 8, 2025 / intive announced today a strategic enterprise partnership with Cursor that accelerates the company's AI-Native Transformation Program. This milestone formalizes a relationship that has been evolving over several months, introducing dedicated engineering support and enterprise-grade enablement that strengthens AI-native engineering capabilities across teams and client engagements.

Additional Positive Results for Omisirge(R) in Treating Severe Aplastic Anemia Presented at ASH

New data presented at the 2025 ASH demonstrates 94% disease free and overall survival rateOmisirge approved by FDA as First Cell Therapy to Treat Severe Aplastic AnemiaKey Highlights of Data Presented at ASH:95% of patients achieved rapid neutrophil recoveryMedian time to neutrophil recovery: 8 daysImmune recovery post-transplant was rapid94% disease-free and overall survivalNo cases of BMT-CTN severe acute graft-versus-host disease (GVHD), or chronic GVHD observedOmisirge approved by the FDA on December 5, 2025 for SAA

Ayrmid Presents New Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease

Motixafortide alone and in combination with natalizumab can support the collection of the large number of stem cells required by gene therapies for sickle cell disease within a single apheresis cycleKey HighlightsMotixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) mobilization predicting 16.9 million and 19.6 million cells/kg collected in a single apheresis session.Motixafortide alone and in combination with natalizumab mobilized 2.7 and 2.8 fold greater HSCs, relative to plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSCs for people with sickle cell disease enabling accelerated access to gene therapiesData from study shows that motixafortide was safe and well toleratedFindings presented at ASH 2025

Ondas Announces Intent to Invest up to $11 Million in Drone Fight Group to Accelerate Access to Advanced Ukrainian Drone Technology

First strategic investment by Ondas Capital intended to strengthen U.S. and allied defense modernization priorities with combat-proven Ukrainian technologiesOndas Capital plans to support localization via U.S.-based, NDAA-compliant manufacturing and integrated customer support, training and sustainment

Snaplii Reminds Shoppers of Special Cashback Offers During Holiday Season

It's the last call for the smart shopping app's holiday promotions, which provide increasing cashback rewards at spending milestones and offer double cashback rewards on select brands through Monday, Dec. 15.

QNX to Showcase Innovations for Software-Defined Vehicles and Mission-Critical Embedded Systems at CES 2026

WATERLOO, ONTARIO / ACCESS Newswire / December 8, 2025 / QNX, a division of BlackBerry Limited (NYSE:BB)(TSX:BB), has announced it will showcase the latest advancements in its mission-critical embedded systems and automotive software product portfolio, including a new demo of its Foundational Vehicle Software Platform developed in collaboration with Vector, at CES 2026.

Greenlane Buys $8 Million worth of BERA, Maintains Approximately $32 Million Cash and Stablecoin Reserves for Berachain Treasury Strategy

BOCA RATON, FL / ACCESS Newswire / December 8, 2025 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (Nasdaq:GNLN), a Berachain-focused digital asset treasury company and global seller of premium cannabis accessories, and subsequent to the Company's press releases issued on October 24, 2025 and November 14, 2025 that disclosed Greenlane's Berachain cryptocurrency treasury strategy (the "Berachain Treasury Strategy"), is providing an update on its BERA token holdings, staking activity, and capital position related to its participation in the Berachain ecosystem.

LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities

BOCA RATON, FL / ACCESS Newswire / December 8, 2025 / In recent years, LIXTE (NASDAQ:LIXT) has been defined by LB-100, its first-in-class PP2A inhibitor with a mechanism that unlocks new therapeutic angles for resistant cancers. The company built its early identity around that science, and for good reason. LB-100 remains one of the few agents capable of disrupting a key cellular checkpoint cancer relies on for survival. Late 2025 added a new dimension to that storyline. With the acquisition of Liora Technologies, LIXTE signaled a transition from a pure biotech into a multi-layered oncology platform. The theme is not reinvention. It is expansion.

The Global Infrastructure of Trust Is Being Rebuilt, and HUB Cyber Security Is Becoming One of Its Architects

TEL AVIS, IL / ACCESS Newswire / December 8, 2025 / For years, cybersecurity companies have trained the market to think in terms of software updates, dashboards, and breach containment. HUB Cyber Security (NASDAQ:HUBC) is operating on an entirely different level. It's not focused on the alerts. It's focused on the foundation, advancing a view of digital trust that begins where most cybersecurity firms end: at the hardware layer, where identity, authenticity, and verification must be absolute.

Resemble AI Raises $13M From Sony Innovation Fund, Okta Ventures and Others to Tackle AI-Generated Threats as Deepfake Cyberattacks Surge Against Global Enterprises

Company Launches Industry's Strongest Detection Model to Protect Digital Integrity and Unveils 2026 Deepfake Threat Predictions

Regentis Biomaterials Commences Trading on NYSE: Set to Transform Cartilage Repair Market with Off-the-Shelf Regenerative Product

Lead product GelrinC®, a hydrogel synchronized erosion and resorbable implant, the only restorative product for knee cartilage repair, is a breakthrough effective and economical procedure to address a large unmet needGelrinC is approved for knee cartilage repair in the European Union and is currently at midpoint in a pivotal FDA trial for the same indication to address a U.S. market of more than 470,000 potential cases annuallyUpcoming expected catalysts include commercial launch in Europe and submission to FDA for approval in U.S.

Optex Systems Holdings Announces Chad George as Chief Executive Officer

RICHARDSON, TX / ACCESS Newswire / December 8, 2025 / Optex Systems Holdings, Inc. (Nasdaq:OPXS), a leading manufacturer of precision optical sighting systems for domestic and global military and commercial applications, is pleased to announce the promotion of Chad George to President and Chief Executive Officer, effective December 20, 2025. Mr. George previously served as President and will now assume full executive leadership of the organization.

Unusual Machines and Dynamic Aerospace Systems Enter Supplier Agreement for U.S.-Made, NDAA-Compliant Drone Components

Partnership supports DAS's expanding commercial logistics operations in the Middle East and Europe

HUB Cyber Security Turns Regulatory Pressure Into Institutional Speed

TEL AVIV, IL / ACCESS Newswire / December 8, 2025 / Global institutions have lived with the same quiet limitation for decades. Regulation keeps tightening, data volumes keep expanding, and the systems responsible for proving compliance cannot keep up. Banks spend months fixing workflow gaps. Asset managers navigate fragmented reporting tools. Digital-asset platforms fight an endless battle to reassure regulators that their operations are clean. The issue has never been intent. It has always been infrastructure. Most compliance architectures were built for an earlier era of finance.

Ayrmid Reports Promising New Real-World Data on Motixafortide for Stem Cell Mobilization in Sickle Cell Disease

Key HighlightsMotixafortide effectively mobilized sufficient hematopoietic stem cells (HSCs) in patients with sickle cell disease enabling accelerated access to gene therapies90% (9 of 10) of patients were able to collect sufficient HSC to enable progress to gene therapy manufacturing86% (6 of 7) of patients had previously failed to collect sufficient cells with plerixaforResults support the use of motixafortide as an effective single-agent mobilizer of HSC for people with sickle cell disease for gene therapiesFindings presented at ASH 2025

Califf Surveying Becomes Leading Supplier of Leica Total Stations in Asia

Singapore-based surveying authority expands Leica product offerings, delivering unmatched accuracy and innovation to engineering, construction, and infrastructure sectors.

Meta partners with news outlets to expand AI content

Meta announced Friday it will integrate content from major news organizations into its artificial intelligence assistant to provide Facebook, Instagram and WhatsApp users with real-time information.

Softbank's Son says super AI could make humans like fish, win Nobel Prize

Softbank CEO and AI investor Masayoshi Son said Friday that advanced artificial intelligence could surpass humans to the extent that "we become fish" and could even win the Nobel Prize in Literature.

Revalia Bio Awarded Up To $26.7 Million ARPA-H Contract Award to Advance Drug Development with Human Data Trials

Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating therapies for patients.

Akanda Is Slowly Controlling the Map Behind Mexico's Telecom Boom

TORONTO, ON / ACCESS Newswire / December 5, 2025 / Akanda Corp. (NASDAQ:AKAN) is no longer behaving like an operator trying to find space inside Mexico's telecom upgrade. The company is acting like the landlord everyone else eventually has to call. Through its wholly owned subsidiary, First Towers & Fiber, Akanda controls the vertical real estate carriers depend on and the horizontal routes that move the data itself. When the infrastructure under a national network begins to consolidate, the companies holding the ground win first. That is the position Akanda has quietly engineered for itself.

FDA approves Omisirge(R) as First Approved Cell Therapy to Treat Severe Aplastic Anemia

Study demonstrated early and sustained hematopoietic recovery and transfusion independenceOmisirge is a new and novel transplant option for patients with SAAAdditional manufacturing capacity for Omisirge will be established in the U.S.Represents a supplementary FDA approval for Omisirge

JRI	0.61%	13.13	$
BCC	-2.74%	82.13	$
CMSC	0.04%	23.96	$
RIO	0.77%	97.09	$
BCE	0.89%	25.8	$
RBGPF	0.12%	82.5	$
CMSD	0.17%	23.8	$
NGG	0.01%	90.28	$
AZN	-1.1%	204.2	$
BTI	1.76%	62.08	$
RELX	1.49%	31.46	$
GSK	-1.42%	59.52	$
VOD	0.77%	15.65	$
BP	-0.87%	38.18	$
RYCEF	2.2%	18.2	$

American Marconi Wireless News - Technology (English)

Featured

St Francis relics go on public show for first time in Italy

AI agent invasion has people trying to pick winners

Last news